Oxford Instruments PLC (OXIG)

Industry Scientific & Technical Instruments


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

2,060.00p

Buy

2,065.00p

arrow-up10.00p (+0.49%)

Prices updated at 18 Dec 2025, 09:41 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Oxford Instruments PLC manufactures technology tools and systems which are used for scientific research, patient monitoring, semiconductor processing and diagnostic imaging. Its segments are Nanotechnology Tools, Industrial Products and Services.

Income statement

20242025
470m501m
242m259m
70m83m
14.8216.48
51m26m
93m64m
Sales, General and administrative133m135m
Interest expenses2m2m
Provision for income taxes21m14m
Operating expenses173m176m
Income before taxes71m40m
Net income available to common shareholders51m26m
0.9070.239
Net interest income3m600,000
Advertising and promotion--
Net investment income, net10m-300,000
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.8950.237
Free cash flow per share0.27090.7583
Book value/share6.48956.2407
Debt equity ratio0.0806670.072321

Balance sheet

20242025
Current assets324m331m
Current liabilities198m183m
Total capital367m377m
Total debt47m41m
Total equity366m376m
Total non current liabilities--
Loans900,000500,000
Total assets606m605m
Total liabilities--
Cash and cash equivalents98m94m
Common stock58m58m

Cash flow

20242025
Cash at beginning of period102m86m
Cash dividends paid-11m-12m
15m33m
Investments (gains) losses-37m-27m
86m85m
Net income--
42m49m
-28m-16m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.